David Silberstein
Förmögenhet: - $ per 2026-08-31
Förmögenhet: - $ per 2026-08-31
David S.
Silberstein currently works at Lantern Pharma, Inc., as Independent Director from 2018, Biological Mimetics, Inc., as Director from 2016, and BioMimetix Pharmaceutical, Inc., as Chief Operating Officer from 2013.
Dr. Silberstein received his doctorate degree from The Trustees of Columbia University in The City of New York.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
LANTERN PHARMA, INC. -.--% | 2026-04-17 | 0 ( -.--% ) | - $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| LANTERN PHARMA INC. | Direktör/Styrelseledamot | 2018-06-01 |
BioMimetix Pharmaceutical, Inc.
BioMimetix Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides development services for biopharmaceutical products | Verksamhetschef | 2013-01-01 |
Biological Mimetics, Inc.
Biological Mimetics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktör/Styrelseledamot | 2016-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioMimetix Pharmaceutical, Inc.
BioMimetix Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides development services for biopharmaceutical products | Commercial Services |
Lantern Pharma, Inc.
Lantern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drug from advanced genomics and artificial intelligence | Health Technology |
Biological Mimetics, Inc.
Biological Mimetics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån